Franklin Resources’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-23,991
| Closed | -$1.41M | – | 2991 |
|
|
2023
Q4 | $1.41M | Sell |
23,991
-777,277
| -97% | -$43.7M | ﹤0.01% | 1515 |
|
|
2023
Q3 | $34.9M | Buy |
801,268
+148,878
| +23% | +$5.32M | 0.02% | 594 |
|
|
2023
Q2 | $23.6M | Buy |
652,390
+22
| +0% | +$906 | 0.01% | 723 |
|
|
2023
Q1 | $24.3M | Sell |
652,368
-84,400
| -11% | -$3.8M | 0.01% | 725 |
|
|
2022
Q4 | $33.4M | Sell |
736,768
-723,425
| -50% | -$46.8M | 0.02% | 646 |
|
|
2022
Q3 | $102M | Buy |
1,460,193
+1,728
| +0.1% | +$128K | 0.06% | 368 |
|
|
2022
Q2 | $97.9M | Buy |
1,458,465
+307,184
| +27% | +$19.5M | 0.05% | 380 |
|
|
2022
Q1 | $94.7M | Sell |
1,151,281
-113,790
| -9% | -$11.6M | 0.04% | 451 |
|
|
2021
Q4 | $186M | Sell |
1,265,071
-16,687
| -1% | -$2.59M | 0.07% | 319 |
|
|
2021
Q3 | $227M | Buy |
1,281,758
+38,489
| +3% | +$6.19M | 0.09% | 270 |
|
|
2021
Q2 | $201M | Buy |
1,243,269
+251,126
| +25% | +$40.3M | 0.08% | 291 |
|
|
2021
Q1 | $170M | Buy |
992,143
+701,778
| +242% | +$139M | 0.07% | 308 |
|
|
2020
Q4 | $63.8M | Buy |
290,365
+76,121
| +36% | +$16.5M | 0.03% | 525 |
|
|
2020
Q3 | $35.6M | Sell |
214,244
-94,927
| -31% | -$13M | 0.02% | 640 |
|
|
2020
Q2 | $38M | Hold |
309,171
| – | – | 0.02% | 599 |
|
|
2020
Q1 | $23.8M | Buy |
309,171
+12,600
| +4% | +$1.13M | 0.02% | 633 |
|
|
2019
Q4 | $38.2M | Sell |
296,571
-21,800
| -7% | -$2.1M | 0.02% | 607 |
|
|
2019
Q3 | $24.8M | Buy |
318,371
+24,420
| +8% | +$2.29M | 0.01% | 697 |
|
|
2019
Q2 | $30.3M | Sell |
293,951
-151,200
| -34% | -$11.8M | 0.02% | 660 |
|
|
2019
Q1 | $32.6M | Buy |
+445,151
| New | +$30.3M | 0.02% | 621 |
|
|
2017
Q2 | – | Sell |
-377,646
| Closed | -$1.96M | – | 1538 |
|
|
2017
Q1 | $1.96M | Hold |
377,646
| – | – | ﹤0.01% | 1250 |
|
|
2016
Q4 | $1.79M | Sell |
377,646
-236,350
| -38% | -$1.29M | ﹤0.01% | 1250 |
|
|
2016
Q3 | $4.06M | Hold |
613,996
| – | – | ﹤0.01% | 1143 |
|
|
2016
Q2 | $3.35M | Hold |
613,996
| – | – | ﹤0.01% | 1168 |
|
|
2016
Q1 | $13.1M | Hold |
613,996
| – | – | 0.01% | 910 |
|
|
2015
Q4 | $19.4M | Sell |
613,996
-62,644
| -9% | -$2.21M | 0.01% | 842 |
|
|
2015
Q3 | $23.3M | Sell |
676,640
-149,206
| -18% | -$4.51M | 0.01% | 800 |
|
|
2015
Q2 | $26M | Buy |
825,846
+23,000
| +3% | +$678K | 0.01% | 827 |
|
|
2015
Q1 | $23.5M | Sell |
802,846
-39,500
| -5% | -$927K | 0.01% | 854 |
|
|
2014
Q4 | $15.6M | Sell |
842,346
-28,999
| -3% | -$489K | 0.01% | 954 |
|
|
2014
Q3 | $15.3M | Sell |
871,345
-160,901
| -16% | -$3M | 0.01% | 956 |
|
|
2014
Q2 | $20.6M | Buy |
1,032,246
+143,500
| +16% | +$2.77M | 0.01% | 865 |
|
|
2014
Q1 | $16.9M | Buy |
888,746
+240,046
| +37% | +$4.99M | 0.01% | 899 |
|
|
2013
Q4 | $10.8M | Buy |
+648,700
| New | +$11.1M | 0.01% | 968 |
|
Other funds holding MRTX
Franklin Resources's MRTX Position: Q1 2024 in Review
Franklin Resources sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 23,991 shares — an estimated $1.41M sold.
Franklin Resources first reported a position in MRTX in Q4 2013 and held it in 34 quarters. The position peaked at $227M in Q3 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- Franklin Resources reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Franklin Resources sold 23,991 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.41M.
- Franklin Resources first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2013 and held it in 34 quarters.
- Franklin Resources's Mirati Therapeutics, Inc. Common Stock position peaked at $227M in Q3 2021.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Franklin Resources's 13F filing for Q1 2024, filed 13 May 2024.